Finerenone for Diabetic Kidney Disease in Type 1 Diabetes — A Fine Answer?
New England Journal of Medicine · 05.03.2026 · 394 (10) · 1019-1020
DOI: 10.1056/nejme2600575 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 05.03.2026. Verfasst von Aleksandra Kukla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN. Die Arbeit nennt 10 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN.
ORCID-Profile: Marie C Hogan
Zitieren
APA
Kukla, A., & Hogan, M. C. (2026). Finerenone for Diabetic Kidney Disease in Type 1 Diabetes — A Fine Answer?. New England Journal of Medicine, 394(10), 1019-1020. https://doi.org/10.1056/nejme2600575
Vancouver
Kukla A, Hogan MC. Finerenone for Diabetic Kidney Disease in Type 1 Diabetes — A Fine Answer?. New England Journal of Medicine. 2026;394(10):1019-1020. doi:10.1056/nejme2600575
BibTeX
@article{Kukla2026,
author = {Kukla, Aleksandra and Hogan, Marie C},
title = {Finerenone for Diabetic Kidney Disease in Type 1 Diabetes — A Fine Answer?},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {10},
pages = {1019--1020},
doi = {10.1056/nejme2600575}
}
EUVIMED